Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis

Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis

Show other versions (1)

<h4>Introduction</h4> Famotidine is a competitive histamine H2-receptor antagonist most commonly used for gastric acid suppression but thought to have potential efficacy in treating patients with Coronavirus disease 2019 (COVID-19). The aims of this systematic review and meta-analysis ar...

Full description

Bibliographic Details
Main Authors: Leonard Chiu, Max Shen, Chun-Han Lo, Nicholas Chiu, Austin Chen, Hyun Joon Shin, Elizabeth Horn Prsic, Chin Hur, Ronald Chow, Benjamin Lebwohl
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568101/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568101/?tool=EBI

Similar Items